BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PBX1
,
calcium channel activity
,
Allergy to pollen
,
Embryo
,
Personalized medicine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CYP3A
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Prostate cancer
Malignant tumor of muscle
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
No compounds found
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
No perturbed genes found
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Gene expression profiling of prostate cancer
Gene Expression Profiles of Head and Neck Squamous Cell Carcinoma (HNSCC) primary tumors
Gene expression profiling of children affected by Alveolar Rhabdomyosarcoma (ARMS)
Explore Curated Studies Results
Literature
Most Relevant Literature
CYP3A-Mediated Carbon-Carbon Bond Cleavages in Drug Metabolism.
Pharmacokinetics of asundexian with combined CYP3A and P-gp inhibitors and an inducer: Target in vit…
Quantitative prediction of CYP3A-mediated drug-drug interactions by correctly estimating fraction me…
Quantitative analysis of the impact of membrane permeability on intestinal first-pass metabolism of …
Signatures of Co-evolution and Co-regulation in the CYP3A and CYP4F Genes in Humans.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Buprenorphine Disposition and CYP3A
Fruquintinib CYP3A Inhibitor and Inducer Study
Surufatinib DDI With a PPI and a CYP3A Inducer
Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel
Effect of CYP3A Genetic Polymorphisms on the Pharmacokinetics of Atorvastatin
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ